--- title: "Lishengpharma: Company executives plan to reduce their holdings by no more than 11,200 shares of the company" type: "News" locale: "en" url: "https://longbridge.com/en/news/266710523.md" description: "36Kr learned that Lishengpharma announced that the company's senior management personnel, Guo Xiaoyan, plans to reduce holdings of the company's shares by no more than 11,200 shares through centralized bidding, with the intended reduction not exceeding 0.0044% of the total share capital after excluding the shares in the repurchase special account" datetime: "2025-11-20T10:36:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/266710523.md) - [en](https://longbridge.com/en/news/266710523.md) - [zh-HK](https://longbridge.com/zh-HK/news/266710523.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/266710523.md) | [繁體中文](https://longbridge.com/zh-HK/news/266710523.md) # Lishengpharma: Company executives plan to reduce their holdings by no more than 11,200 shares of the company 36Kr learned that Lishengpharma announced that the company's senior management personnel, Guo Xiaoyan, plans to reduce holdings of the company's shares by no more than 11,200 shares through centralized bidding, with the planned reduction not exceeding 0.0044% of the total share capital after excluding the number of shares in the repurchase special account ### Related Stocks - [Lishengpharma (002393.CN)](https://longbridge.com/en/quote/002393.CN.md) ## Related News & Research - [Lisheng Pharmaceutical, Tianjin Development Holdings Affiliate, Reports Indicative 2025 Earnings Growth](https://longbridge.com/en/news/273656376.md) - [Hongkong Land Buys Back More Shares](https://longbridge.com/en/news/278374786.md) - [Bank of Ireland Cancels Shares After Latest Buy-Back Tranche](https://longbridge.com/en/news/278043154.md) - [Hoshine Silicon Industry plans share private placement](https://longbridge.com/en/news/278085320.md) - [Fosun International Stakeholders to Increase Shareholding](https://longbridge.com/en/news/278304413.md)